Population Pharmacogenomics
Population Pharmacogenomics is a subdiscipline of pharmacogenomics that investigates the influence of genetic variation across populations on drug response to optimize therapeutic efficacy and safety at the group level.
896
Publications
56.8K
Citations
5.7K
Authors
1.8K
Institutions
Publications per year
2017–2026
237
Parents
Children
Ancestry-informed PharmacogenomicsBiobanks In PharmacogenomicsGlobal Pharmacogenomic Reference PanelsHaplotype-based PharmacogenomicsLegal Issues In PharmacogenomicsLinkage Disequilibrium In PharmacogenomicsPharmacogenetic Variant FrequenciesPharmacogenomic EquityPolygenic Drug Response PredictionPopulation Allele Frequency Mapping
896
Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose
Mark J. Rieder, Alex P. Reiner, Brian F. Gage et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text
1–5 of 896
5.7K
19
h-index
17
h-index
16
h-index
15
h-index
13
h-index
1–5 of 5.7K
1.8K
University of California, San Francisco
San Francisco, United States
24 h-index
118 publications
17.3K citations
Stanford University
Stanford, United States
23 h-index
86 publications
13.6K citations

Karolinska Institutet
Stockholm, Sweden
22 h-index
78 publications
6.1K citations
University of Chicago
Chicago, United States
21 h-index
90 publications
9K citations
University of Washington
Seattle, United States
20 h-index
114 publications
16.8K citations

Vanderbilt University
Nashville, United States
20 h-index
88 publications
9K citations
PharmacoGenetics (China)
Hong Kong, China
19 h-index
157 publications
6.4K citations
University of Florida
Gainesville, United States
18 h-index
86 publications
6.8K citations
1–8 of 1.8K
95 publications · 3.6K citations
35
h-index
CPT · 46 publications · 6K citations
34
h-index
52 publications · 2.4K citations
28
h-index
37 publications · 2K citations
24
h-index
24 publications · 1.3K citations
20
h-index
1–5